drugset / Trial / NCT03977649
A Functional MRI Study on Erenumab Treatment Effects in Episodic Migraine Patients
RandomizedCrossoverQuadruple-blindTreatment
Summary
The purpose of this study is to investigate the effects of erenumab on central sensitization and brain networks connectivity of migraine patients
Timeline
- Start
- 2019-07-30
- Primary completion
- 2021-07-05
- Completion
- 2021-07-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Erenumab | Monoclonal antibody | 140 mg | Subcutaneous |